共 50 条
- [1] Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study[J]. ADVANCES IN THERAPY, 2019, 36 (01) : 86 - 100Shirai, KohjiFujita, ToruTanaka, MichitakaFujii, YukaShimomasuda, MasatsuguSakai, SoichiSamukawa, Yoshishige
- [2] A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer's Disease[J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 163 - 179Nakamura, YuImai, YukimichiShigeta, MasahiroGraf, AnaShirahase, ToruKim, HyosungFujii, AkifumiMori, JojiHomma, Akira
- [3] Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study[J]. DIABETES CARE, 2014, 37 (11) : 3121 - 3123Simpson, Richard W.Nicholson, Geoffrey C.Proietto, JosephSarah, AlanaSanders, Kerrie M.Phillips, GabrielleChambers, JoMacGinley, RobOrford, NeilWalder, KenKrippner, GuySkoff, KathyWacher, Vincent J.
- [4] Atherosclerotic cardiovascular risk assessment in a 24-week, randomized, double-blind, placebo-controlled study of aldafermin[J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S617 - S617Gunn, Nadege T.Ling, LeiNeff, GuyGuy, CynthiaBashir, MustafaParedes, AngeloFrias, JuanYounes, Ziad H.Trotter, James F.Moussa, SamKohli, AnitaConnelly, Margery A.Nelson, KristenGottwald, MildredChang, WilliamYan, AndrewDePaoli, AlexLieu, HsiaoHarrison, Stephen
- [5] Effects of Varenicline in Adult Smokers: A Multinational, 24-Week, Randomized, Double-Blind, Placebo-Controlled Study[J]. CLINICAL THERAPEUTICS, 2011, 33 (04) : 465 - 477Bolliger, Chris T.Issa, Jaqueline S.Posadas-Valay, RodolfoSafwat, TarekAbreu, PaulaCorreia, Eurico A.Park, Peter W.Chopra, Pravin
- [6] EFFICACY AND SAFETY OF ROMILKIMAB IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC): RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 24-WEEK, PROOF OF CONCEPT STUDY[J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 157 - 158Allanore, Y.Wung, P.Soubrane, C.Esperet, C.Frederic, M.Bejuit, R.Lahmar, A.Khanna, D.Denton, C.
- [7] Efficacy and Safety of Romilkimab in Diffuse Cutaneous Systemic Sclerosis (dcSSc): A Randomized, Double-Blind, Placebo-Controlled, 24-week, Proof of Concept Study[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71Allanore, YannickDenton, ChristopherKhanna, DineshSoubrane, ChristinaEsperet, CorinneMarrache, FredericBejuit, RaphaelLahmar, AmelWung, Peter
- [8] Efficacy and safety of canagliflozin rnonotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (11) : 1501 - 1515Inagaki, NobuyaKondo, KazuokiYoshinari, ToruTakahashi, NahokoSusuta, YutakaKuki, Hideki
- [9] A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder[J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (10) : 1270 - 1278Montgomery, SANil, RDürr-Pal, NLoft, HBoulenger, JP
- [10] LIPID MANAGEMENT IN A 24-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ALDAFERMIN (NGM282)[J]. HEPATOLOGY, 2020, 72 : 1022 - 1023Gunn, Nadege T.Ling, LeiNeff, GuyGuy, Cynthia D.Bashir, MustafaFrias, Juan PabloYounes, Ziad H.Trotter, James F.Moussa, SamKohli, AnitaConnelly, Margery A.Nelson, KristinGottwald, MildredChang, WilliamYan, Andrew Z.DePaoli, AlexLieu, HsiaoHarrison, Stephen A.